CAM
ONC

CIF Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

CIF Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$7.44M Hold
20,500
– – 8.73% 3
2021
Q2 		$7.04M Buy
20,500
+3,100
+18% +$1.03M 6.72% 5
2021
Q1 		$6.06M Buy
17,400
+1,100
+7% +$364K 12.32% 3
2020
Q4 		$4.21M Buy
+16,300
New +$4.49M 5.14% 6

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

CIF Asset Management's ONC Position: Q3 2021 in Review

CIF Asset Management held its BeOne Medicines Ltd (ONC) position steady in Q3 2021 at 20,500 shares worth $7.44M. The position accounts for 8.73% of the portfolio, ranked #3.

CIF Asset Management first reported a position in ONC in Q4 2020 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold ONC as of Q3 2021.

  • CIF Asset Management held 20,500 shares of BeOne Medicines Ltd worth $7.44M as of Q3 2021.
  • CIF Asset Management left its BeOne Medicines Ltd share count unchanged in Q3 2021.
  • BeOne Medicines Ltd made up 8.73% of CIF Asset Management's portfolio in Q3 2021, its #3 holding.
  • CIF Asset Management first reported a position in BeOne Medicines Ltd in Q4 2020 and has held it in 4 quarters since.
  • 254 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2021.

Based on CIF Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.